PRGO (Perrigo Co) Asset Impairment Charge: $ Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PRGO Perrigo Co PLC PRGO
54 GF Score
Price $13.56
GF Value $23.76
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Perrigo Co Asset Impairment Charge?

Perrigo Co PRGO +0.59% 54 Asset Impairment Charge is $ Mil as of Jun. 2026. GuruFocus rates PRGO with a GF Score™ of 54/100 and a GF Value™ of $23.76 (Possible Value Trap). The stock has 6 warning signs investors should review.

Perrigo Co's Asset Impairment Charge for the three months ended in Jun. 2026 was $ Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2026 was $ Mil.

Perrigo Co Asset Impairment Charge Related Terms

Perrigo Co Asset Impairment Charge Historical Data

* Premium members only.

The historical data trend for Perrigo Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perrigo Co Asset Impairment Charge Chart

Perrigo Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Perrigo Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
PRGO
54GF Score
Perrigo Co PLC PRGO
Asset Impairment Charge is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perrigo Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $ Mil.

What does a Asset Impairment Charge of $ Mil mean?
Perrigo Co (PRGO) has a Asset Impairment Charge of $ Mil as of Jun. 2026.
Is Perrigo Co's Asset Impairment Charge too high?
Perrigo Co's current Asset Impairment Charge is $ Mil. Overall, Perrigo Co has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Perrigo Co's Asset Impairment Charge compare to ALVO and TRLV?
Perrigo Co's Asset Impairment Charge of $ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Impairment Charge for a Drug Manufacturers company?
A good Asset Impairment Charge depends on the Drug Manufacturers industry context. However, Asset Impairment Charge should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Impairment Charge mean?
A high Asset Impairment Charge can signal that a stock is expensive relative to its fundamentals. Perrigo Co's current Asset Impairment Charge is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perrigo Co stock overvalued right now?
Based on GuruFocus' analysis, Perrigo Co (PRGO) is currently considered Possible Value Trap. The stock's GF Value™ is $23.76, compared to a current price of $13.56 — trading 42.9% below its estimated fair value. The current Asset Impairment Charge is $ Mil. Perrigo Co's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Impairment Charge calculated?
Asset Impairment Charge is calculated from a company's financial statements. For Perrigo Co (PRGO), the current Asset Impairment Charge is $ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perrigo Co (PRGO) Overvalued in 2026?

Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued. The current stock price of $13.56 is trading 42.9% below its estimated GF Value™ of $23.76. GuruFocus considers Perrigo Co to be Possible Value Trap.

Key valuation signals for PRGO:

  • Asset Impairment Charge: $ Mil
  • GF Value™: $23.76 vs. price of $13.56 (42.9% below fair value)
  • GF Score™: 54/100 with 6 warning signs

No single metric tells the full story. See the PRGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perrigo Co Business Description

Address The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
54GF Score

Get the complete analysis for PRGO

Asset Impairment Charge is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.56
Price
$23.76
GF Value